机译:有丝分裂抑制不足1(Mad1L1)的表达增加与乳腺癌中的紫杉醇治疗不良和对紫杉醇治疗不敏感
Department of Breast Surgery Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Breast Surgery Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Breast Surgery Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Pathology Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Pathology Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Medical Record Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Breast Surgery Affiliated Tumour Hospital Harbin Medical University Harbin China;
Department of Breast Surgery Affiliated Tumour Hospital Harbin Medical University Harbin China;
Breast cancer; Chromosomal instability; MAD1L1; Mitotic checkpoint; Taxol;
机译:有丝分裂抑制不足1(Mad1L1)的表达增加与乳腺癌中的紫杉醇治疗不良和对紫杉醇治疗不敏感
机译:精子相关抗原9过表达与乳腺癌预后差和对紫杉醇治疗不敏感有关
机译:有丝分裂阻滞缺陷样1与小细胞肺癌手术切除后预后不良相关
机译:集成深度神经网络和支持向量机的人类乳腺癌预后预测:乳腺癌预后预测的有监督特征提取和分类
机译:能量平衡,乳腺癌风险和乳腺癌后的预后:研究饮食和身体活动的复杂作用。
机译:BMPRIB的低表达表明乳腺癌的预后不良并且对紫杉烷-蒽环类化学疗法不敏感
机译:在腔内乳腺癌中Six1的表达预示不良预后并通过激活细胞外信号调节激酶和转化生长因子-β信号通路促进肿瘤起始细胞的增加